PreMarket Price
PreMarket Price
Astera Labs, Inc. Common Stock (ALAB) logo

Stock Analysis

Astera Labs, Inc. Common StockALAB

Price:$285.82Market Closed-5.35%at last close

P/E 134.20×· 3Y range 71.98–308.64×· 32th percentile of history

Sector: Technology · Industry: Semiconductors & Related Devices

AnalystsStrong Buy29 analysts
Mkt Cap 49.18BP/E 133.1ROE 27.1%
Low 72.0×134.2×High 308.6×

P/E 134.2× sits at the 32nd percentile of its 2.5735797399041753-year history.

Cash $0.83BNet cash $0.83BDebt $0.00B

Cash covers 38959% of debt · Q2 2024.

Profilev35g50p95h75q30m30

PMP Verdict

Mixed fundamentals, fairly valued

Strengths

  • Profitability95
  • Financial Health75

Risks

  • Quality30
  • Growth50
Revenue +120.2% CAGRP/E 133× · 32nd pctl

Mixed picture — no clear quality or value edge.

Market context

-5.4% today· Z 1.3σ

Bull Case

  • ✓Altman Z 183.5 — safe-zone balance sheet
  • ✓ROE 27.1% — efficient capital deployment
  • ✓Revenue CAGR 120.2% — durable top-line growth

What's happening with ALAB

ALAB vs. CSCO: Which AI Infrastructure Stock Is a Better Buy? — Yahoo, 9h agoLast big move: -10.0% on 2026-10-14

Profile

Valuation — 35/100 (Weak) P/E vs own history: 32th pct → 20/25 FCF yield: 0.6% → 5/25 P/S: 40.9x → 0/25 EV/EBIT: n/a → 10/25Valuation35Growth — 50/100 (Moderate) Revenue CAGR: 120.2% → 25/25 Net income CAGR: n/a → 0/25 EPS CAGR 5Y: n/a → 0/25 Fwd implied growth: 107.2% → 25/25Growth50Profitability — 95/100 (Strong) ROIC: 123.6% → 25/25 ROE: 27.1% → 25/25 Net margin: 30.7% → 25/25 Operating margin: 22.8% → 20/25Profitability95Financial Health — 75/100 (Strong) Altman Z: 183.49 → 25/25 Current ratio: 10.24 → 25/25 Interest coverage: no interest expense → 25/25 Net cash / debt: n/a → 0/25Health75Quality — 30/100 (Weak) Piotroski F: 5/9 → 15/25 Beneish M: 1.26 → 0/25 FCF conversion: 75% → 15/25 Margin stability: σ 55.3% → 0/25Quality30Moat — 30/100 (Weak) ROIC >12% years: 1/4 yrs → 0/25 Median gross margin: 74.6% → 25/25 FCF-positive years: 2/4 yrs → 5/25 Worst-year net margin: worst -73.0% → 0/25Moat30

Strong profitability and financial health; earnings quality, moat and valuation lag behind.

How is each axis scored?
  • Valuation35/100 · Weak
    • P/E vs own history (32th pct)20/25
    • FCF yield (0.6%)5/25
    • P/S (40.9x)0/25
    • EV/EBIT (n/a)10/25
  • Growth50/100 · Moderate
    • Revenue CAGR (120.2%)25/25
    • Net income CAGR (n/a)0/25
    • EPS CAGR 5Y (n/a)0/25
    • Fwd implied growth (107.2%)25/25
  • Profitability95/100 · Strong
    • ROIC (123.6%)25/25
    • ROE (27.1%)25/25
    • Net margin (30.7%)25/25
    • Operating margin (22.8%)20/25
  • Financial Health75/100 · Strong
    • Altman Z (183.49)25/25
    • Current ratio (10.24)25/25
    • Interest coverage (no interest expense)25/25
    • Net cash / debt (n/a)0/25
  • Quality30/100 · Weak
    • Piotroski F (5/9)15/25
    • Beneish M (1.26)0/25
    • FCF conversion (75%)15/25
    • Margin stability (σ 55.3%)0/25
  • Moat30/100 · Weak
    • ROIC >12% years (1/4 yrs)0/25
    • Median gross margin (74.6%)25/25
    • FCF-positive years (2/4 yrs)5/25
    • Worst-year net margin (worst -73.0%)0/25

Risk Flags

  • ⚠Beneish M 1.26 — earnings-manipulation flag
  • ⚠SBC 16.2% of revenue — real dilution cost
  • ⚠3 loss-making years in recent history

About Astera Labs, Inc. Common Stock

Astera Labs Inc designs and delivers semiconductor-based connectivity solutions for cloud and AI infrastructure. Show more

Its Intelligent Connectivity Platform integrates semiconductor technology, microcontrollers, sensors, and software to enhance performance, scalability, and data management. The company offers products such as integrated circuits (ICs), boards, and modules, catering to hyperscalers and system OEMs. The company's solutions focus on data, network, and memory management in AI-driven platforms. Geographically, the company operates in Singapore, China, Taiwan, and United States, of which maximum revenue is derived from United States.

Headquarters: SAN JOSE, CA · Employees: 756 · Website ↗

Price History

Weekly Candlestick Chart — up to 5Y

Key Metrics

Financial snapshot · Tap any metric for its definition and grade

TTM Snapshot

trailing twelve months · YoY
Revenue
1.2B+98%
Op. Income
273.4M+546%
Net Income
369.5M+269%
EPS
2.03+261%
Operating CF
335.7M+35%
Free CF
276.7M+32%

Valuation

35D
P/E (TTM)133.1xD

Grade D: ExpensivePrice / TTM EPS (own statements) — vs own 3Y history: 72.0x–308.6x · 32nd pct

P/FCF189.4xD

Grade D: ExpensivePrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative

FCF Yield0.6%C

Grade C: LowTTM (OCF − CapEx) / Market Cap — vs own 3Y history: 0.2%–1.8% · 23rd pct

P/S (TTM)40.92xD

Grade D: ExpensivePrice / TTM Revenue (own statements) — vs own 3Y history: 17.3x–113.3x · 59th pct

EV/EBITDA183.2xD

Grade D: ExpensiveEnterprise value / EBITDA (Finnhub) — capital-structure neutral — vs own 3Y history: 154.0x–363.7x · 13th pct

EV/Sales43.5xD

Grade D: Very expensiveEnterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple

Forward P/E64.2xD

Grade D: ExpensivePrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth

P/B Ratio36.07xD

Grade D: Very expensivePrice to Book Value. Neg. equity = heavy buybacks

PEG Ratio4.03D

Grade D: ExpensiveFinnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)

Dividend Yield—

TTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress

Payout Ratio—

Dividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable

P/E vs own 3Y historyBelow average · 32nd pct

Profitability

95A+
ROIC123.6%A

Grade A: MoatNOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat

ROE27.1%A

Grade A: StrongReturn on Equity. Neg. equity = heavy buybacks

ROA22.7%A

Grade A: StrongReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit

Net Margin30.7%A

Grade A: HighNet Income / Revenue

Operating Margin22.8%C

Grade C: AverageTTM EBIT / TTM Revenue

Gross Margin75.1%A

Grade A: PremiumGross Profit / Revenue

FCF Margin23.0%A

Grade A: HighFCF / Revenue

True FCF Margin6.8%C

Grade C: AverageTTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost

Growth

50C
Revenue CAGR120.2%A

Grade A: HighCompound annual revenue growth (up to 5Y depending on data availability)

Net Income CAGR—

Compound annual net income growth (up to 5Y depending on data availability)

EPS CAGR (5Y)—

Compound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0

Implied EPS Growth107.2%A

Grade A: HighAnalyst forward EPS (normalized basis) vs our GAAP TTM EPS — different bases, so extreme values usually mark cyclically depressed TTM earnings, not real growth

Dilution (5Y)—

Share count change over 5Y

SBC / Net Income52.8%D

Grade D: HighStock-based comp/Net income. >30% = dilution risk

SBC / Revenue16.2%D

Grade D: HighTTM stock-based comp / TTM Revenue

Financial Health

75B+
Altman Z-Score183.49A

Grade A: SafeBankruptcy risk. >3 Safe, <1.8 Distress

Current Ratio10.24xA

Grade A: HighCurrent Assets/Liabilities

Quick Ratio9.36xA

Grade A: High(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory

Interest Coverage—

EBIT/Interest. >10 Strong

Debt Repayment—

Years to repay net debt via FCF

Net Debt/EBIT—

Leverage. <2x Low, >4x High

Debt/Equity0.00xA

Grade A: LowDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.

Cash / Debt—

Cash covers how much of total debt. >1 = could repay all debt from cash

Quality

30D
Piotroski F-Score5/9C

Grade C: AverageFinancial strength 0–9. >7 Strong

Beneish M-Score1.26D

Grade D: RiskyEarnings manipulation risk. < -2.22 Safe

FCF Conversion74.9%C

Grade C: AverageFCF / Net Income

Margin Stability55.3%D

Grade D: VolatileEBIT margin std deviation. Lower = stable

Capex / Revenue4.9%A

Grade A: Asset-lightTTM CapEx / TTM Revenue — high % = capital-hungry business

Asset Turnover0.74xC

Grade C: AverageRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales

3/4 Loss Years

Insider Transactions

SEC Form 4 · 8 records
Open-market · 90dBuy —Sell $7.9M (12)Other filings 3Net open-market selling

P/S codes are the directional signal; grants, option exercises and tax withholding carry none. Form 4 doesn't flag 10b5-1 plans — scheduled sales may appear within open-market sells.

Recent insider transactions
Trade dateTransactionShares
Dyckerhoff Stefan A
Filed
SellOpen market sale
-661
Dyckerhoff Stefan A
Filed
SellOpen market sale
-8333
Dyckerhoff Stefan A
Filed
SellOpen market sale
-3505
HURLSTON MICHAEL E.
Filed
Grant / award
+72
Dyckerhoff Stefan A
Filed
Grant / award
+68
Show 3 more filings
Additional recent insider transactions
Trade dateTransactionShares
BARRATT CRAIG H
Filed
Grant / award
+68
Dyckerhoff Stefan A
Filed
SellOpen market sale
-32
Dyckerhoff Stefan A
Filed
SellOpen market sale
-407
More metrics — Moat, Per Share, Balance Sheet, Market

Moat

30D
ROIC >12% Years1/4 yrsD

Grade D: WeakShare of completed fiscal years with ROIC > 12% — measures multi-year capital-return durability

Gross Margin (Med.)74.6%A

Grade A: DurableMedian annual gross margin across available fiscal years — pricing-power durability

FCF-Positive Years2/4 yrsD

Grade D: WeakShare of completed fiscal years with positive free cash flow

Net Margin Floor-73.0%D

Grade D: WeakWeakest annual net margin across completed fiscal years — recession/downcycle resilience

Per Share

EPS (TTM)$2.13

Own TTM net income / shares — same earnings basis as P/E

Cash / Share$7.22

Cash & short-term investments per share (Finnhub)

Book Value / Share$9.95

Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks

Balance Sheet

Total Debt—

Total debt obligations (short + long term)

Cash & Equiv.$1.19B

Cash and short-term investments

Net Debt—

Total Debt minus Cash. Negative = Net Cash position

Total Equity$1.36B

Shareholders' equity (book value)

Asset / Liability9.11xA

Grade A: SolidTotal Assets / Total Liabilities

Market

Market Cap$49.18B

Current Market Capitalization

Beta3.73D

Grade D: High volatilityPrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings

How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.

Financials as of Jun 2026 · Ratio snapshot Oct 17, 2026

Key Insights: Astera Labs, Inc. Common Stock (ALAB)

ALAB is down 5.35% at the last close. Piotroski F-Score of 5/9 indicates mixed fundamentals for Astera Labs, Inc. Common Stock. Altman Z-Score of 183.49 sits comfortably in the safe zone (≥ 2.99), indicating low bankruptcy risk. Beneish M-Score of 1.26 is above the −1.78 flag threshold, a signal that reported earnings warrant closer scrutiny.

  • Revenue has compounded at roughly 120% annually — a strong growth profile.
  • Astera Labs, Inc. Common Stock converts about 23% of revenue into free cash flow — strong cash generation.
  • Astera Labs, Inc. Common Stock posted a net loss in 3 of 4 available completed fiscal years (2022–2025).
  • Return on equity of 27.1% is well above the market average.

See how ALAB ranks on the Capex Tracker — top 50 capital spenders compared.

Recent Market Moves

See all ALAB moves →
DateSessionPriceMoveZ-Score
Oct 14After-hours292.99-9.96%-2.32
Oct 8Regular343.32-10.18%-2.38
Oct 8After-hours346.04-9.47%-2.23
Sep 21Pre-market313.49+3.38%2.25
Sep 21Regular342.25+12.86%8.57

Frequently Asked Questions about ALAB

What is the current Astera Labs, Inc. Common Stock (ALAB) stock price?

ALAB is trading at $285.82 at the last market close, down 5.35% on the session. PreMarketPrice tracks ALAB pre-market, intraday and after-hours prices.

Is ALAB stock a buy right now?

PreMarketPrice's quantitative model rates Astera Labs, Inc. Common Stock's financial health at 75/100. This is a data-driven snapshot of fundamentals, not investment advice.

Is ALAB stock overvalued?

Astera Labs, Inc. Common Stock trades at a trailing P/E of 133.1 and our valuation score rates it 35/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.

When does Astera Labs, Inc. Common Stock report earnings?

No confirmed earnings date is currently scheduled for ALAB. The Earnings section lists recent reports and updates as dates are announced.

What sector does Astera Labs, Inc. Common Stock operate in?

Astera Labs, Inc. Common Stock operates in the Technology sector, within the Semiconductors & Related Devices industry. The Related Stocks section lists sector peers for comparison.

What does Astera Labs, Inc. Common Stock do?

Astera Labs Inc designs and delivers semiconductor-based connectivity solutions for cloud and AI infrastructure.

About Astera Labs, Inc. Common Stock (ALAB) Stock

Astera Labs, Inc. Common Stock (ALAB) is a US-listed stock operating in the Technology sector, specifically the Semiconductors & Related Devices industry. As of the latest update, Astera Labs, Inc. Common Stock is trading at $285.82, down 5.35% on the day with a market capitalization of $49.2 billion. The financial health score for ALAB is 75/100, which indicates excellent financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for ALAB stock.

ALAB Stock Analysis & Key Metrics

On PreMarketPrice, you can track Astera Labs, Inc. Common Stock (ALAB) across multiple dimensions:

Is ALAB a Good Stock to Buy?

This page provides data-driven analysis to help you evaluate Astera Labs, Inc. Common Stock (ALAB) as an investment. The financial health score of 75/100 suggests excellent financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.

Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.Astera Labs, Inc. Common Stock (ALAB) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.

Related opportunities

Moving today in Technology
More Semiconductors & Related Devices stocks
Cheaper alternatives
Similar fundamentals